Catalyst Wire Dossier Catalyst Wire Dossier

Rituximab plus CHOP immunochemotherapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rituximab plus CHOP immunochemotherapy, covering 2018-01-16 to 2018-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Abbreviated 3 Cycles of Rituximab Plus CHOP(Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy in Patients With Completely Excised LocalizedGastrointestinal CD(Cluster of Differentiation Antigen)20(+) Diffuse Large B-cell Lymphoma [Phase 2]

See pricing